Cargando…

In-hospital mortality and length of stay among patients with infective endocarditis and solid organ transplant: A study from National Inpatient Sample 2016–2019

Infective endocarditis (IE) is a rare but serious complication following a Solid Organ Transplant (SOT). Due to the lack of sufficient studies, we aimed to compare in-hospital mortality and length of stay (LOS) of patients primarily admitted for IE (index or principal hospitalization) with history o...

Descripción completa

Detalles Bibliográficos
Autores principales: Baral, Nischit, Volgman, Annabelle Santos, Gupta, Tripti, Kunadi, Arvind, Khan, Mahin R., Kambalapalli, Soumya, Changezi, Hameem U., Tracy, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189868/
https://www.ncbi.nlm.nih.gov/pubmed/35706945
http://dx.doi.org/10.1016/j.heliyon.2022.e09655
_version_ 1784725681604657152
author Baral, Nischit
Volgman, Annabelle Santos
Gupta, Tripti
Kunadi, Arvind
Khan, Mahin R.
Kambalapalli, Soumya
Changezi, Hameem U.
Tracy, Melissa
author_facet Baral, Nischit
Volgman, Annabelle Santos
Gupta, Tripti
Kunadi, Arvind
Khan, Mahin R.
Kambalapalli, Soumya
Changezi, Hameem U.
Tracy, Melissa
author_sort Baral, Nischit
collection PubMed
description Infective endocarditis (IE) is a rare but serious complication following a Solid Organ Transplant (SOT). Due to the lack of sufficient studies, we aimed to compare in-hospital mortality and length of stay (LOS) of patients primarily admitted for IE (index or principal hospitalization) with history of SOT, including the subgroup of heart or lung transplant (HLT), to those without a history of SOT (non-SOT) or HLT (non-HLT). We used the 2016–2019 National Inpatient Sample, the largest all-payer inpatient hospital data from Healthcare Cost and Utilization Project (HCUP), including patients 18 years or older with IE, as a principal diagnosis for hospitalization. From 2016 to 2019, there were 56,330 principal or index hospitalizations for IE. Among them, 0.6 % (n = 327) were SOT recipients, 0.1% (n = 68) were HLT recipients, and 41.4% were females. The mean age was 51.9 ± 19.2 years. Compared to non-SOT controls, SOT recipients were older (mean age 59.3 vs. 51.8 years; P = 0.002) and had higher Charlson-comorbidity-index (CCI) of 3 or more (87.7% vs. 33.2%; p < 0.001). SOT status was not statistically significant for a higher or lower odds of in-hospital mortality (adjusted odds ratio (aOR) 0.7; 95% confidence interval (CI): 0.2, 2.4; p = 0.60) or increased or decreased LOS (coefficient: -0.1, 95% CI: -0.4, 0.1; p = 0.23) among index IE hospitalizations after controlling for age, sex, race, hospital-region, hospital-teaching status, income, insurance status, and CCI. HLT status was also not associated with higher or lower odds of in-hospital mortality (aOR 1.4; 95% CI: 0.2, 13.1; p = 0.77) or increased or decreased LOS (coefficient: -0.1, 95% CI: -0.3, 0.5; p = 0.59). From 2016 to 2019, the rate of index IE hospitalization trends from 37.8 to 41.4 per 100,000 overall hospitalizations (p = 0.001). We found the rate of index IE hospitalizations increasing with time. Among index IE hospitalizations, SOT, including a subgroup of HLT recipients, have similar in-hospital mortality and LOS compared to non-SOT or non-HLT groups. We need a larger sample size to comment on outcomes of IE hospitalizations with the HLT subgroup.
format Online
Article
Text
id pubmed-9189868
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91898682022-06-14 In-hospital mortality and length of stay among patients with infective endocarditis and solid organ transplant: A study from National Inpatient Sample 2016–2019 Baral, Nischit Volgman, Annabelle Santos Gupta, Tripti Kunadi, Arvind Khan, Mahin R. Kambalapalli, Soumya Changezi, Hameem U. Tracy, Melissa Heliyon Research Article Infective endocarditis (IE) is a rare but serious complication following a Solid Organ Transplant (SOT). Due to the lack of sufficient studies, we aimed to compare in-hospital mortality and length of stay (LOS) of patients primarily admitted for IE (index or principal hospitalization) with history of SOT, including the subgroup of heart or lung transplant (HLT), to those without a history of SOT (non-SOT) or HLT (non-HLT). We used the 2016–2019 National Inpatient Sample, the largest all-payer inpatient hospital data from Healthcare Cost and Utilization Project (HCUP), including patients 18 years or older with IE, as a principal diagnosis for hospitalization. From 2016 to 2019, there were 56,330 principal or index hospitalizations for IE. Among them, 0.6 % (n = 327) were SOT recipients, 0.1% (n = 68) were HLT recipients, and 41.4% were females. The mean age was 51.9 ± 19.2 years. Compared to non-SOT controls, SOT recipients were older (mean age 59.3 vs. 51.8 years; P = 0.002) and had higher Charlson-comorbidity-index (CCI) of 3 or more (87.7% vs. 33.2%; p < 0.001). SOT status was not statistically significant for a higher or lower odds of in-hospital mortality (adjusted odds ratio (aOR) 0.7; 95% confidence interval (CI): 0.2, 2.4; p = 0.60) or increased or decreased LOS (coefficient: -0.1, 95% CI: -0.4, 0.1; p = 0.23) among index IE hospitalizations after controlling for age, sex, race, hospital-region, hospital-teaching status, income, insurance status, and CCI. HLT status was also not associated with higher or lower odds of in-hospital mortality (aOR 1.4; 95% CI: 0.2, 13.1; p = 0.77) or increased or decreased LOS (coefficient: -0.1, 95% CI: -0.3, 0.5; p = 0.59). From 2016 to 2019, the rate of index IE hospitalization trends from 37.8 to 41.4 per 100,000 overall hospitalizations (p = 0.001). We found the rate of index IE hospitalizations increasing with time. Among index IE hospitalizations, SOT, including a subgroup of HLT recipients, have similar in-hospital mortality and LOS compared to non-SOT or non-HLT groups. We need a larger sample size to comment on outcomes of IE hospitalizations with the HLT subgroup. Elsevier 2022-06-04 /pmc/articles/PMC9189868/ /pubmed/35706945 http://dx.doi.org/10.1016/j.heliyon.2022.e09655 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
Baral, Nischit
Volgman, Annabelle Santos
Gupta, Tripti
Kunadi, Arvind
Khan, Mahin R.
Kambalapalli, Soumya
Changezi, Hameem U.
Tracy, Melissa
In-hospital mortality and length of stay among patients with infective endocarditis and solid organ transplant: A study from National Inpatient Sample 2016–2019
title In-hospital mortality and length of stay among patients with infective endocarditis and solid organ transplant: A study from National Inpatient Sample 2016–2019
title_full In-hospital mortality and length of stay among patients with infective endocarditis and solid organ transplant: A study from National Inpatient Sample 2016–2019
title_fullStr In-hospital mortality and length of stay among patients with infective endocarditis and solid organ transplant: A study from National Inpatient Sample 2016–2019
title_full_unstemmed In-hospital mortality and length of stay among patients with infective endocarditis and solid organ transplant: A study from National Inpatient Sample 2016–2019
title_short In-hospital mortality and length of stay among patients with infective endocarditis and solid organ transplant: A study from National Inpatient Sample 2016–2019
title_sort in-hospital mortality and length of stay among patients with infective endocarditis and solid organ transplant: a study from national inpatient sample 2016–2019
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189868/
https://www.ncbi.nlm.nih.gov/pubmed/35706945
http://dx.doi.org/10.1016/j.heliyon.2022.e09655
work_keys_str_mv AT baralnischit inhospitalmortalityandlengthofstayamongpatientswithinfectiveendocarditisandsolidorgantransplantastudyfromnationalinpatientsample20162019
AT volgmanannabellesantos inhospitalmortalityandlengthofstayamongpatientswithinfectiveendocarditisandsolidorgantransplantastudyfromnationalinpatientsample20162019
AT guptatripti inhospitalmortalityandlengthofstayamongpatientswithinfectiveendocarditisandsolidorgantransplantastudyfromnationalinpatientsample20162019
AT kunadiarvind inhospitalmortalityandlengthofstayamongpatientswithinfectiveendocarditisandsolidorgantransplantastudyfromnationalinpatientsample20162019
AT khanmahinr inhospitalmortalityandlengthofstayamongpatientswithinfectiveendocarditisandsolidorgantransplantastudyfromnationalinpatientsample20162019
AT kambalapallisoumya inhospitalmortalityandlengthofstayamongpatientswithinfectiveendocarditisandsolidorgantransplantastudyfromnationalinpatientsample20162019
AT changezihameemu inhospitalmortalityandlengthofstayamongpatientswithinfectiveendocarditisandsolidorgantransplantastudyfromnationalinpatientsample20162019
AT tracymelissa inhospitalmortalityandlengthofstayamongpatientswithinfectiveendocarditisandsolidorgantransplantastudyfromnationalinpatientsample20162019